Status:
UNKNOWN
HYPNAYA Feasibility Study
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Conditions:
AYA Cancer Patients
Eligibility:
All Genders
18-39 years
Brief Summary
Adolescents and young adults (AYAs) with a cancer diagnosis experience high levels of stress during and after treatment. Hypnotherapy as supportive treatment throughout regular cancer care may reduce ...
Detailed Description
Study design: The HYPNAYA feasibility study is an interventional prospective single center cohort study with pre- and post-measurements. Patients will be consecutively recruited at the medical oncolog...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Consecutive AYA patients undergoing systemic treatment or follow-up up to 6 months after finishing medical treatment at the Amsterdam University Medical Centers in Amsterdam, will be invited to participate.
- The Dutch definition of AYA is patients aged 18-39 years at cancer diagnosis.
- All patients need to be fluent in Dutch
- Able to understand the informed consent form
- Willing to provide written informed consent.
- Exclusion criteria
- Patients that are actively treated by a psychiatrist will not be able to participate in this study to prevent interference with ongoing psychiatric treatment.
- Patients that are mentally incompetent (based on the opinion of the treating physician) will be excluded.
- Patients that previously received hypnotherapy will also be excluded.
Exclusion
Key Trial Info
Start Date :
July 17 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06021093
Start Date
July 17 2023
End Date
October 1 2024
Last Update
September 7 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Amsterdam UMC, location VUMC
Amsterdam, North Holland, Netherlands, 1081HV
2
Amsterdam UMC, location AMC
Amsterdam, North Holland, Netherlands, 1105AZ